The global Janus Kinase 3 (JAK3) Inhibitor Market is poised for substantial expansion, driven by the emergence of highly targeted oral therapies for a wide spectrum of chronic autoimmune and inflammatory diseases. As a critical component of the JAK-STAT signaling pathway, JAK3 inhibition offers a powerful mechanism to modulate immune responses, particularly in conditions where current... https://avinashkumbharkar.blogspot.com/2025/10/surging-demand-for-energy-shots-and.html